Cargando…
Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease
BACKGROUND: The objective of this study is to assess the frequency of autoantibodies against 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) in a single center myositis cohort and to analyze associations with statin exposure, clinical features, and outcome of disease course. METHODS: A tota...
Autores principales: | Szczesny, Piotr, Barsotti, Simone, Nennesmo, Inger, Danielsson, Olof, Dastmalchi, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114810/ https://www.ncbi.nlm.nih.gov/pubmed/35603214 http://dx.doi.org/10.3389/fimmu.2022.866701 |
Ejemplares similares
-
Diversiform Etiologies for Post-stroke Depression
por: Wang, Zan, et al.
Publicado: (2019) -
Anti-HMGCR Myopathy without Exposure to Statins: A Case Report
por: Ferriz Vivancos, Jorge, et al.
Publicado: (2022) -
Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed
por: Carvalho, Alzira Alves Siqueira, et al.
Publicado: (2018) -
Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin
por: Allenbach, Yves, et al.
Publicado: (2014) -
Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
por: Bjarnadottir, Olöf, et al.
Publicado: (2020)